Serum biomarkers for nonalcoholic fatty liver disease: Are we there yet? Editorial A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non Alcoholic Fatty Liver Disease Glutathione in the Treatment of Fatty Liver NASH NAFLD Pantothenic Acid Derivatives Modulate Oxidative Stress and Hepatic Fibrosis in Bile Duct Ligation Induced Cholestatic Liver Injury Frontiers Glutathione: Pharmacological aspects and implications for clinical use in non alcoholic fatty liver disease